25
RUSSIAN JOURNAL OF ANAESTHESIOLOGY AND REANIMATOLOGY 2, 2019
of disseminated intravascular coagulation in sepsis and va li da tion of scoring
systems.
J Crit Care
. 2018;50:23-30.
64. Thrombosis and hemostasis study group in hematology branch of the Chi-
ne se Medical Association. Chinese experts’ consensus on the diagnosis
and treatment of disseminated intravascular coagulation (2012 ed.).
Chin J
Hematol
. 2012;33(11):978-979.
65. Wada H, Thachil J, Di Nisio M, Mathew P, et al. The Scientific Stan dar-
di za tion Committee on DIC of the International
Society on Throm bo sis
Haemostasis. Guidance for diagnosis and treatment of DIC from har mo ni-
za ti on of the recommendations from three guidelines.
J Thromb Haemost
.
2013;4:42.
66. Asakura H, Takahashi H, Uchiyama T, Eguchi Y, et al. DIC subcommittee
of the Japanese Society on Thrombosis and Hemostasis. Proposal for new
diagnostic criteria for DIC from the Japanese Society on Thrombosis and
Hemostasis.
Thromb J
. 2016;14:42.
67. Lee D, Lee B, Jeung K, Park J, et al. Performance of 5 disseminated intra-
vas cu lar coagulation score systems in predicting mortality in patients with
severe trauma.
Medicine (Baltimore)
. 2018;97(33):11912.
68. Kobayashi T. Obstetrical disseminated intravascular coagulation score.
J
Obstet Gynaecol Res
. 2014;40:1500-1506.
69. Yoshihara M, Uno K, Tano S, Mayama M, Ukai M, Kondo S, et al. The
efficacy of recombinant human soluble thrombomodulin
for obstetric dis-
se mi na ted intravascular coagulation: a retrospective study.
Crit Care
. 2015
Oct;19:369.
70. Erez O. Disseminated intravascular coagulation in pregnancy – Clinical
phenotypes and diagnostic scores.
Thromb Res.
2017;151(Suppl 1):56-60.
71. Clark S, Romero R, Dildy G, Callaghan W, et al. Proposed diagnostic criteria
for the case definition of amniotic fluid embolism in research studies.
Am J
Obstet Gynecol
. 2016;215(4):408-412.
72. Nadisauskiene R, Kliucinskas M, Dobozinskas P, Kacerauskiene J. The
impact of postpartum haemorrhage management guidelines implemented in
clinical practice: a systematic review of the literature.
Eur J Obstet Gynecol
Reprod Biol
. 2014;178:21-26.
73. McQuilten Z, Crighton G, Brunskill S, Morison JK, et al. Optimal Dose,
Timing and Ratio of Blood Products in Massive Transfusion:
Results from
a Systematic Review.
Transfus Med Rev
. 2018;32(1):6-15.
74. Müller M, Straat M, Meijers J, Klinkspoor J, et al. Fresh frozen plasma
transfusion fails to influence the hemostatic balance in critically ill patients
with a coagulopathy.
J Thromb Haemost
. 2015;13(6):989-997.
75. Lancé M, Ninivaggi M, Schols S, Feijge M, et al. Perioperative dilutional
coagulopathy treated with fresh frozen plasma and fibrinogen concentrate:
a prospective randomized intervention trial.
Vox Sang
. 2012;103(1):25-34.
76. Levy J, Rossaint R, Zacharowski K, Spahn D.
What is the evidence for
platelet transfusion in perioperative settings?
Vox Sang
. 2017;112(8):704-712.
77. Llau J, Acosta F, Escolar G, Fernández-Mondéjar E, et al. Multidisciplinary
con se nsus document on the management of massive haemorrhage (HEMOMAS
document).
Med Intensiva
. 2015;39(8):483-504.
78. Jones R, de Lloyd L, Kealaher E, Lilley G, et al. Platelet count and trans-
fusion requirements during moderate or severe postpartum haemorrhage.
Anaesthesia
. 2016;71(6):648-656.
79. Collis R, Guasch E. Managing major obstetric haemorrhage: Phar ma co the-
ra py and transfusion.
Best Pract Res Clin Anaesthesiol
. 2017;31(1):107-124.
80. Shah A, Stanworth S, McKechnie S. Evidence and triggers for the transfusion
of blood and blood products.
Anaesthesia
. 2015;70(Suppl 1):3-5.
81. Franchini M, Mengoli C, Cruciani M, Bergamini V, et al.
Safety and efficacy
of tranexamic acid for prevention of obstetric haemorrhage: an updated
systematic review and metaanalysis.
Blood Transfus
. 2018;16(4):329-337.
82. Shakur H, Beaumont D, Pavord S, Gayet-Ageron A, et al. Antifibrinolytic
drugs for treating primary postpartum haemorrhage.
Cochrane Database Syst
Rev
. 2018;2:CD012964.
83. WOMAN Trial Collaborators. Effect of early tranexamic acid administration
on mortality, hysterectomy, and other morbidities in women with post-
Достарыңызбен бөлісу: